45
Participants
Start Date
March 31, 2015
Primary Completion Date
June 30, 2019
Study Completion Date
December 31, 2021
Pembrolizumab
Administration of 200 mg MK-3475 once every 3 weeks
Epacadostat
100mg taken by mouth twice daily
Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Collaborators (1)
Merck Sharp & Dohme LLC
INDUSTRY
Incyte Corporation
INDUSTRY
Georgetown University
OTHER